Two recently published studies from California-based non-profit research organization RAND Corporation revealed very interesting data.

The first research deals with why young adults living in Los Angeles County acquire medical cannabis cards.

The second study provides data on how the neighborhood density and storefront signage of medical cannabis dispensaries influence consumption rates and associations among the youth.

It seems that whenever a new recreational cannabis market rolls out, reports of exaggerated lines, product shortages, and store closures never seem to be far behind.

Some of Canada's biggest cannabis producers are facing proposed class-action lawsuits in the United States after investors were hit with steep financial losses in the stock market.

At least nine U.S. law firms are pursuing cases against Canopy Growth, Aurora Cannabis and Hexo Corp. in American courts.

Although the allegations vary, each pot producer is accused of misleading investors or failing to disclose certain problems with their businesses. When those problems became publicly known, the lawsuits claim, share prices plunged and investors were stuck with losses.

"[Investors] are mad; they were taken by surprise," said Reed Kathrein, a lawyer at Hagens Berman Sobol Shapiro LLP, which is pursuing claims against all three producers.

Marijuana seizures at the U.S. border jumped in the year after Canada legalized recreational cannabis.

Figures provided by the U.S. Customs and Border Protection (CBP) show American officers seized 2,214 kg of marijuana from travellers entering the U.S. between Nov. 1, 2018 and Oct. 31, 2019, up from just 1,259 kg over the same period a year earlier.

That's an increase in volume of about 75 per cent.

The upswing was less significant in terms of the number of individual seizures recorded: 3,917 in the year after legalization, compared to 3,139 incidents the year before.

CPB spokesman Kris Grogan said he sees the increase as more of an "uptick" than a drastic spike.

If you read enough cannabis-related articles online, you will eventually come across the “talking to your kids about pot” guide. They have been written by many people and contain various nuggets of advice, but what most of them have in common is trying to communicate ways to parents to communicate to their children that marijuana is something they should stay away from.

There’s obviously nothing wrong with that, but there are a couple risks parents run: 1) lying to your children can erode their trust in other things you have told them and 2) lying to your children about marijuana could inadvertently drive them to experiment with some other, more dangerous behavior.

Lightning-fast. High-speed. Breakneck. 

This is how quick the modern cannabis experience is changing — and nobody knows this better than the consumers who are witnessing this rapid growth firsthand. From dispensary shelves filled with products you’ve never seen before to the increasingly serious push for legal cannabis nationwide, to cannabis consumption lounges opening up in a few lucky locations, we are living through the cannabis renaissance. And yet, more expansive change is still on the horizon.  

Just in case you didn’t know, beverages with cannabidiol (CBD) won’t get you high. In fact, these “rescue” drinks can actually make you feel focused and calm (which you surely want on a chilly night before you head to sleep). If you are to read articles from American Marijuana, you’ll discover how these drinks can actually give significant health and therapeutic benefits – clearly opposite from the idea of being at blazed. Amazingly, CBD products are found to reduce stress, anxiety, insomnia, body pain and etc.

Coming into 2019, marijuana stock investors had a lot to look forward to. Canada had become the first industrialized country in the modern era to legalize recreational cannabis in Oct. 2018, derivative pot products were expected to hit Canadian dispensaries later in 2019, and a number of U.S. states appeared to be on the verge of adult-use legalization. This was supposed to be the year that cannabis stocks turned the corner to profitability and really matured.

Unfortunately, this vision hasn't been anywhere close to reality for the weed industry in 2019.

We now have less than a week to go before we say goodbye to 2019, and the year can't end soon enough for marijuana stock investors.

When 2019 began, the expectation was that this would be the year the cannabis industry really matured. Sales were expected to skyrocket with Canada allowing recreational weed sales and derivative pot products positioned to hit dispensary shelves during the fourth quarter. But as the year played out, these projections turned out to be nothing more than a pipe dream, with the end result being billions of dollars lost by pot stock investors.